产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# DF3122, RRID:AB_2835499.
展开/折叠
Heterogeneous nuclear ribonucleoprotein A2; Heterogeneous nuclear ribonucleoprotein A2/B1; Heterogeneous nuclear ribonucleoprotein B1; Heterogeneous nuclear ribonucleoproteins A2/B1; hnRNP A2 / hnRNP B1; hnRNP A2; hnRNP A2/B1; hnRNP B1; hnRNP-A2; hnRNP-B1; hnRNPA2; Hnrnpa2b1; hnRNPB1; HNRPA2; HNRPA2B1; HNRPB1; Nuclear ribonucleoprotein particle A2 protein; RNP A2; RNP B1; RNP-A2; RNP-B1; RNPA2; RNPB1; ROA2_HUMAN; SNRPB1;
抗原和靶标
- P22626 ROA2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MEKTLETVPLERKKREKEQFRKLFIGGLSFETTEESLRNYYEQWGKLTDCVVMRDPASKRSRGFGFVTFSSMAEVDAAMAARPHSIDGRVVEPKRAVAREESGKPGAHVTVKKLFVGGIKEDTEEHHLRDYFEEYGKIDTIEIITDRQSGKKRGFGFVTFDDHDPVDKIVLQKYHTINGHNAEVRKALSRQEMQEVQSSRSGRGGNFGFGDSRGGGGNFGPGPGSNFRGGSDGYGSGRGFGDGYNGYGGGPGGGNFGGSPGYGGGRGGYGGGGPGYGNQGGGYGGGYDNYGGGNYGSGNYNDFGNYNQQPSNYGPMKSGNFGGSRNMGGPYGGGNYGPGGSGGSGGYGGRSRY
种属预测
score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。
High(score>80) Medium(80>score>50) Low(score<50) No confidence
翻译修饰 - P22626 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
M1 | Acetylation | Uniprot | |
K3 | Acetylation | Uniprot | |
K3 | Ubiquitination | Uniprot | |
T4 | Phosphorylation | Uniprot | |
T7 | Phosphorylation | Uniprot | |
K13 | Ubiquitination | Uniprot | |
K22 | Acetylation | Uniprot | |
K22 | Ubiquitination | Uniprot | |
S29 | Phosphorylation | Uniprot | |
T32 | Phosphorylation | Uniprot | |
S36 | Phosphorylation | Uniprot | |
R38 | Methylation | Uniprot | |
Y40 | Phosphorylation | Uniprot | |
Y41 | Phosphorylation | Uniprot | |
K46 | Acetylation | Uniprot | |
K46 | Methylation | Uniprot | |
K46 | Sumoylation | Uniprot | |
K46 | Ubiquitination | Uniprot | |
T48 | Phosphorylation | Uniprot | |
S58 | Phosphorylation | Uniprot | |
K59 | Acetylation | Uniprot | |
K59 | Ubiquitination | Uniprot | |
S70 | Phosphorylation | Uniprot | |
S71 | Phosphorylation | Uniprot | |
S85 | Phosphorylation | Uniprot | |
K94 | Acetylation | Uniprot | |
K94 | Ubiquitination | Uniprot | |
S102 | Phosphorylation | Uniprot | |
K104 | Acetylation | Uniprot | |
K104 | Sumoylation | Uniprot | |
K104 | Ubiquitination | Uniprot | |
K112 | Acetylation | Uniprot | |
K112 | Ubiquitination | Uniprot | |
K113 | Ubiquitination | Uniprot | |
K120 | Acetylation | Uniprot | |
K120 | Sumoylation | Uniprot | |
K120 | Ubiquitination | Uniprot | |
R129 | Methylation | Uniprot | |
Y131 | Phosphorylation | Uniprot | |
Y135 | Phosphorylation | Uniprot | |
K137 | Ubiquitination | Uniprot | |
T140 | Phosphorylation | Uniprot | |
T145 | Phosphorylation | Uniprot | |
R147 | Methylation | Uniprot | |
S149 | Phosphorylation | Uniprot | |
K151 | Ubiquitination | Uniprot | |
R153 | Methylation | Uniprot | |
T159 | Phosphorylation | O14757 (CHEK1) | Uniprot |
K168 | Acetylation | Uniprot | |
K168 | Sumoylation | Uniprot | |
K168 | Ubiquitination | Uniprot | |
K173 | Acetylation | Uniprot | |
K173 | Sumoylation | Uniprot | |
K173 | Ubiquitination | Uniprot | |
Y174 | Phosphorylation | Uniprot | |
T176 | Phosphorylation | Uniprot | |
K186 | Sumoylation | Uniprot | |
S189 | Phosphorylation | Uniprot | |
S198 | Phosphorylation | Uniprot | |
R200 | Methylation | Uniprot | |
S201 | Phosphorylation | Uniprot | |
R203 | Methylation | Uniprot | |
S212 | Phosphorylation | Uniprot | |
R213 | Methylation | Uniprot | |
S225 | Phosphorylation | Uniprot | |
R228 | Methylation | Uniprot | |
S231 | Phosphorylation | Uniprot | |
S236 | Phosphorylation | Uniprot | |
R238 | Methylation | Uniprot | |
Y244 | Phosphorylation | Uniprot | |
Y247 | Phosphorylation | Uniprot | |
S259 | Phosphorylation | Uniprot | |
Y262 | Phosphorylation | Uniprot | |
R266 | Methylation | Uniprot | |
Y287 | Phosphorylation | Uniprot | |
Y290 | Phosphorylation | Uniprot | |
Y295 | Phosphorylation | Uniprot | |
S297 | Phosphorylation | Uniprot | |
Y300 | Phosphorylation | Uniprot | |
Y306 | Phosphorylation | Uniprot | |
S311 | Phosphorylation | Uniprot | |
Y313 | Phosphorylation | Uniprot | |
K317 | Sumoylation | Uniprot | |
S318 | Phosphorylation | Uniprot | |
S324 | Phosphorylation | Uniprot | |
R325 | Methylation | Uniprot | |
Y331 | Phosphorylation | Uniprot | |
Y336 | Phosphorylation | Uniprot | |
S341 | Phosphorylation | Uniprot | |
S344 | Phosphorylation | Uniprot | |
Y347 | Phosphorylation | Uniprot | |
R350 | Methylation | Uniprot | |
S351 | Phosphorylation | Uniprot | |
R352 | Methylation | Uniprot | |
Y353 | Phosphorylation | Uniprot |
研究背景
Heterogeneous nuclear ribonucleoprotein (hnRNP) that associates with nascent pre-mRNAs, packaging them into hnRNP particles. The hnRNP particle arrangement on nascent hnRNA is non-random and sequence-dependent and serves to condense and stabilize the transcripts and minimize tangling and knotting. Packaging plays a role in various processes such as transcription, pre-mRNA processing, RNA nuclear export, subcellular location, mRNA translation and stability of mature mRNAs. Forms hnRNP particles with at least 20 other different hnRNP and heterogeneous nuclear RNA in the nucleus. Involved in transport of specific mRNAs to the cytoplasm in oligodendrocytes and neurons: acts by specifically recognizing and binding the A2RE (21 nucleotide hnRNP A2 response element) or the A2RE11 (derivative 11 nucleotide oligonucleotide) sequence motifs present on some mRNAs, and promotes their transport to the cytoplasm. Specifically binds single-stranded telomeric DNA sequences, protecting telomeric DNA repeat against endonuclease digestion (By similarity). Also binds other RNA molecules, such as primary miRNA (pri-miRNAs): acts as a nuclear 'reader' of the N6-methyladenosine (m6A) mark by specifically recognizing and binding a subset of nuclear m6A-containing pri-miRNAs. Binding to m6A-containing pri-miRNAs promotes pri-miRNA processing by enhancing binding of DGCR8 to pri-miRNA transcripts. Involved in miRNA sorting into exosomes following sumoylation, possibly by binding (m6A)-containing pre-miRNAs. Acts as a regulator of efficiency of mRNA splicing, possibly by binding to m6A-containing pre-mRNAs. Plays also a role in the activation of the innate immune response. Mechanistically, senses the presence of viral DNA in the nucleus, homodimerizes and is demethylated by JMJD6. In turn, translocates to the cytoplasm where it activates the TBK1-IRF3 pathway, leading to interferon alpha/beta production.
(Microbial infection) Involved in the transport of HIV-1 genomic RNA out of the nucleus, to the microtubule organizing center (MTOC), and then from the MTOC to the cytoplasm: acts by specifically recognizing and binding the A2RE (21 nucleotide hnRNP A2 response element) sequence motifs present on HIV-1 genomic RNA, and promotes its transport.
Sumoylated in exosomes, promoting miRNAs-binding.
Asymmetric dimethylation at Arg-266 constitutes the major methylation site (By similarity). According to a report, methylation affects subcellular location and promotes nuclear localization. According to another report, methylation at Arg-266 does not influence nucleocytoplasmic shuttling (By similarity).
Nucleus. Nucleus>Nucleoplasm. Cytoplasm. Cytoplasmic granule. Secreted>Extracellular exosome.
Note: Localized in cytoplasmic mRNP granules containing untranslated mRNAs (PubMed:17289661). Component of ribonucleosomes (PubMed:17289661). Not found in the nucleolus (PubMed:17289661). Found in exosomes following sumoylation (PubMed:24356509).
Nucleus. Cytoplasm.
Note: Predominantly nucleoplasmic, however is also found in the cytoplasm of cells in some tissues (PubMed:17289661).
Homodimer; dimerization is required for nucleocytoplasmic translocation. Identified in the spliceosome C complex. Identified in a IGF2BP1-dependent mRNP granule complex containing untranslated mRNAs. Interacts with IGF2BP1. Interacts with C9orf72. Interacts with DGCR8. Interacts with TARDBP. Interacts with CKAP5. Interacts with TBK1. Interacts with STING1. Interacts with SRC.
The low complexity (LC) region is intrinsically disordered. When incubated at high concentration, it is able to polymerize into labile, amyloid-like fibers and form cross-beta polymerization structures, probably driving the formation of hydrogels. In contrast to irreversible, pathogenic amyloids, the fibers polymerized from LC regions disassemble upon dilution. A number of evidence suggests that formation of cross-beta structures by LC regions mediate the formation of RNA granules, liquid-like droplets, and hydrogels.
文献引用
Application: WB Species: Human Sample: RPMI 8226 cells
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.